arrow
N

Nicole Bechmann

Institute for Clinical Chemistry and Laboratory Medicine
H指数:31
被引数:2,603

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Tumor Necrosis is Associated with an Increased Metastatic and Cardiovascular Risk in Paragangliomas: A Single-Center Series and Meta-Analysis Comparing Necrosis and Cystic Degeneration in Paragangliomas

肿瘤坏死与副神经节瘤的转移和心血管风险增加相关:比较副神经节瘤中坏死和囊性退化的单中心病例系列和荟萃分析

2026-08-220
OAAI
P30 - ECE_3844 - Patients with primary aldosteronism and mild autonomous cortisol secretion (MACS) have increased hybrid steroids compared to patients without MACS: evidence from LC-MS/MS steroid profiling

P30 - ECE_3844 - 与无轻度自主皮质醇分泌(MACS)的患者相比,原发性醛固酮增多症合并轻度自主皮质醇分泌(MACS)的患者具有升高的杂合类固醇:LC-MS/MS类固醇谱的证据

2026-08-100
OAAI
EP55 - ECE_3941 - Identification of false-positive dexamethasone suppression tests using LC-MS/MS

EP55 - ECE_3941 - 使用LC-MS/MS识别地塞米松抑制试验的假阳性结果

2026-08-100
OAAI
OC7.6 - ECE_2870 - SOX2-positive cells in pheochromocytoma and paraganglioma: implications for tumour initiation and maintenance

OC7.6 - ECE_2870 - SOX2阳性细胞在嗜铬细胞瘤和副神经节瘤中的作用:对肿瘤起始和维持的启示

2026-08-100
OAAI
EP1790 - LBA_ECE_1129 - Clinical presentation of cystic or necrotic paragangliomas: insights from a single-center study and meta-analysis

EP1790 - LBA_ECE_1129 - 囊性或坏死性副神经节瘤的临床表现:单中心研究及荟萃分析的启示

2026-08-100
OAAI
Glucocorticoids induce a phagocytic C1Q+ macrophage phenotype primed for IFNγ-dependent CXCL9 secretion

糖皮质激素诱导一种吞噬性C1Q+巨噬细胞表型,该表型已准备好分泌IFNγ依赖性的CXCL9

2026-05-180
OAAI
Phaeochromocytomas and paragangliomas harbour tumour-initiating SOX2+stem cells

嗜铬细胞瘤和副神经节瘤含有肿瘤起始的SOX2阳性干细胞

2026-05-011
PRE
Continuous flow-through steady state system for in vitro characterization of CYP11B2 inhibitors-Impact on enzyme kinetics of steroidogenesis

连续流动稳态系统用于体外表征CYP11B2抑制剂-对类固醇生成酶动力学的影响

2025-06-010
OAAI
Impact of sex hormones on pheochromocytomas, paragangliomas, and gastroenteropancreatic neuroendocrine tumors

性激素对嗜铬细胞瘤,副神经节瘤和胃肠胰腺神经内分泌肿瘤的影响

2025-01-101
PRE
Long-Term Persistence of Glycemic Dysregulation in Patients With a History of Pheochromocytoma/Paraganglioma
2025-01-020
OA